Genome Atlantic is part of the Innovation solutionPublished: May 16th 2018
The Conference Board of Canada’s recently released Innovation Scorecard ranks most Canadian provinces low on Business Enterprise R&D. Genome Atlantic is part of the solution. Private sector investment makes up about ¼ of our R&D portfolio. Check out the Business Enterprise Expenditure on R&D graph that is part of our Impact to Date.